Adient (ADNT Quick QuoteADNT - Free Report) reported $3.73 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 1.1%. EPS of $0.52 for the same period compares to $0.52 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $3.59 billion, representing a surprise of +4.01%. The company delivered an EPS surprise of -17.46%, with the consensus EPS estimate being $0.63.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Adient performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net Sales- Americas: $1.92 billion versus the three-analyst average estimate of $1.76 billion. The reported number represents a year-over-year change of +7.2%.
• Net Sales- Eliminations: $-24 million versus $-28.01 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -7.7% change.
• Net Sales- Asia: $785 million versus $778.94 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +0.3% change.
• Net Sales- EMEA: $1.05 billion compared to the $1.08 billion average estimate based on three analysts. The reported number represents a change of -8% year over year.

View all Key Company Metrics for Adient here>>>

Shares of Adient have returned -3.4% over the past month versus the Zacks S&P 500 composite's -2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.